LINC00266-4P

Across TCGA pan-cancer cohorts, LINC00266-4P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated LINC00266-4P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC00266-4P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00266-4P expression acts as an unfavorable survival marker.

COAD and LGG are the cancer types where LINC00266-4P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.160	0.689	.017	36	view →
LGG	DFS	Tertile	All	0.148	0.739	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

LINC00266-4P–COAD (DFS)

Open the COAD breakdown →